Avantium and AMS start collaboration to develop and commercialize Crystal Structure Prediction

Amsterdam, The Netherlands and Freiburg, Germany: 6 November 2009 - Avantium and Avant-garde Materials Simulations (AMS) announced today that they have entered into a collaboration for the further development and commercialization of Crystal Structure Prediction (CSP) with AMS' GRACE software.

Pharmaceutical companies can use CSP to predict the crystal structures of their drug compounds. CSP provides an essential approach to significantly reduce the risk of missing a more stable crystal form.

In the partnership AMS will further develop the software to accelerate the calculations and broaden the range of compounds for which it can be used. AMS will also perform the predictions for third parties. Avantium will develop efficient experimental strategies to physically generate the predicted crystal forms and commercialize Crystal Structure Prediction as a stand-alone service or in combination with experimental programs.

More info on the press release or Avantium's website.


Next > Avantium appoints Gunnar Staaf as CEO Pharma

Previous > Capricorn Venture Partners expands its senior team and launches Capricorn Health-tech Fund